JNJ-38893777
CAS No. 951135-00-5
JNJ-38893777 ( JNJ38893777 )
Catalog No. M16802 CAS No. 951135-00-5
JNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJNJ-38893777
-
NoteResearch use only, not for human use.
-
Brief DescriptionJNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.
-
DescriptionJNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.Pain Phase 1 Clinical
-
SynonymsJNJ38893777
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRP/TRPV Channel
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number951135-00-5
-
Formula Weight536.53
-
Molecular FormulaC26H26F6N6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name2-(1-piperidinyl)-N-[4-(trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)-2-pyridinyl]-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Manitpisitkul P, et al. Clin Drug Investig. 2015 Jun;35(6):353-63.
2. Meents JE, et al. J Headache Pain. 2015;16:57.
2. Meents JE, et al. J Headache Pain. 2015;16:57.
molnova catalog
related products
-
Methyl Kakuol
Methyl Kakuol is an agonist of TRPA1 with an EC50 of 0.27 μM and can be used in studies about acting as an active ingredient in MBST constituent Asiasari Radix.
-
SAR7334
SAR7334 is a potent and specific inhibitor of TRPC6(IC50 of 7.9 nM).
-
Evifacotrep
Evifacotrep, a short transient receptor potential channel 5 ( TRPC5 ) antagonist (WO2020061162, compound 100), can be used for the research of neurological diseases .